STEER World appoints Dhiraj Tiwari as CFO
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Phase 3 study results will form the basis for future discussions with global regulatory authorities
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG)
The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Brimonidine Tartrate Ophthalmic Solution, 0.1% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Subscribe To Our Newsletter & Stay Updated